# Biomat USA Inc – FDA Inspection, Apr 14, 2026

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/443d0135-e7a6-42e7-818d-cda593ea65e0
Source feed: FDA_Inspections

> FDA inspection 1312336 of Biomat USA Inc, April 14, 2026. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 606 and 630. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1312336
- Company Name: Biomat USA Inc
- Inspection Date: 2026-04-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 1068403 - 2018-08-23

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elyshia-q-danaher/73046c15-abb1-431e-8a76-59c7e8c1604a)

Company: https://www.keypedia.com/companies/biomat-usa-inc/49424971-1c03-4233-80ea-a6572e5fae2a

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
